Morton Goldberg, Director at EYEGATE PHARMACEUTICALS INC (EYEG), sold 21,878 shares at $3.37 ($72K) on 2016-06-03, disclosed to the SEC on 2016-06-07.
Open-market sale of $72k EYEG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.37 | 4,650 | $16K | 21.7% |
| 2 | $3.37 | 4,650 | $16K | 21.7% |
| 3 | $3.25 | 5,543 | $18K | 24.9% |
| 4 | $3.25 | 5,543 | $18K | 24.9% |
| 5 | $3.31 | 746 | $2K | 3.4% |
| 6 | $3.31 | 746 |
| $2K |
| 3.4% |
| Total | $3.31 avg | 21,878 | $72K | 100% |
| Filing → |
| EYEG | SELL | 2017-03-06 | $27K | — | Filing → |
| EYEG | SELL | 2016-06-15 | $47K | — | Filing → |